Mycophenolic acid D3
| Product Name | Mycophenolic acid D3 |
|---|---|
| Alternate Names | Mycophenolic acid Stable Isotopes, Stable Isotopes of Mycophenolic acid |
| CAT No. | CS-O-06796 |
| CAS No. | 1185242-90-3 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 323.36 g/mol |
| Mol. For. | C₁₇H₁₇D₃O₆ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Mycophenolic acid |
| Purity | 95% |
| Therapeutic | Immunosuppressants |
| Smileys | CC1=C(COC2=O)C2=C(O)C(C/C=C(C)/CCC(O)=O)=C1OC([2H])([2H])[2H] |
| Canonical Smiles | CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O |
| InchIKey | HPNSFSBZBAHARI-HZIIEIAOSA-N |
| Inchl | InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+/i3D3 |
| IUPAC | (E)-6-[4-hydroxy-7-methyl-3-oxo-6-(trideuteriomethoxy)-1H-2-benzofuran-5-yl]-4-methylhex-4-enoic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Mycophenolic acid D3 is a deuterated version of the immunosuppressive drug mycophenolic acid. Mycophenolic acid is widely used as an immunosuppressant in organ transplantation and autoimmune diseases. Its mechanism of action involves inhibiting the enzyme inosine monophosphate dehydrogenase, which is essential for the de novo synthesis of guanine nucleotides. This leads to a reduction in the production of T and B lymphocytes, which are responsible for the immune response.
Mycophenolic acid D3 has the same mechanism of action as mycophenolic acid, but with the added benefit of being labeled with deuterium. This labeling is useful in pharmacokinetic studies as it allows for the measurement of drug metabolism and distribution in the body. Deuterium labeling also increases drug stability and reduces the risk of drug-drug interactions.
Mycophenolic acid D3 is available as a powder for oral administration and is typically used in clinical research studies. It is important to note that mycophenolic acid D3 is not currently approved for clinical use and should only be used in research settings.
In summary, mycophenolic acid D3 is a deuterated version of the immunosuppressive drug mycophenolic acid that is used for pharmacokinetic studies. Its mechanism of action involves inhibiting the enzyme inosine monophosphate dehydrogenase, leading to a reduction in T and B lymphocyte production. Mycophenolic acid D3 has the added benefit of increased drug stability and reduced risk of drug-drug interactions.
Get an Instant Quote
Related Compounds
O-Methyl Mycophenolic Acid-D6 |